Impel Pharmaceuticals Ownership 2024 | Who Owns Impel Pharmaceuticals Now?
Institutional Ownership
11.63%
Insider Ownership
0.52%
Retail Ownership
87.85%
Institutional Holders
2.00
Impel Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ST GERMAIN D J CO INC | - | - | - | -1,500 | -100.00% | - | Mar 31, 2024 |
VENBIO PARTNERS LLC | - | - | - | -2,759,791 | -100.00% | - | Mar 31, 2024 |
Impel Pharmaceuticals's largest institutional shareholder is ST GERMAIN D J CO INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ST GERMAIN D J CO INC | - | - | - | -1,500 | -100.00% | - | Mar 31, 2024 |
VENBIO PARTNERS LLC | - | - | - | -2,759,791 | -100.00% | - | Mar 31, 2024 |
The largest Impel Pharmaceuticals shareholder by % of total assets is ST GERMAIN D J CO INC. The company owns 0.00 shares of Impel Pharmaceuticals (IMPL), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ST GERMAIN D J CO INC | - | - | - | -1,500 | -100.00% | - | Mar 31, 2024 |
VENBIO PARTNERS LLC | - | - | - | -2,759,791 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Impel Pharmaceuticals's largest institutional buyer is ST GERMAIN D J CO INC. The company purchased -1.50K stocks of IMPL, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VENBIO PARTNERS LLC | - | - | - | -2,759,791 | -100.00% | - | Mar 31, 2024 |
ST GERMAIN D J CO INC | - | - | - | -1,500 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Impel Pharmaceuticals's biggest institutional seller is VENBIO PARTNERS LLC. The company sold -2.76M shares of IMPL, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VENBIO PARTNERS LLC | - | - | - | -2,759,791 | -100.00% | - | Mar 31, 2024 |
ST GERMAIN D J CO INC | - | - | - | -1,500 | -100.00% | - | Mar 31, 2024 |
Impel Pharmaceuticals's largest sold out institutional shareholder by shares sold is VENBIO PARTNERS LLC, sold -2.76M shares, valued at -, as of undefined.
Impel Pharmaceuticals Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY COMMONWEALTH TRUST | 0.03% | 87,484 | - | - | Feb 29, 2024 |
BRIDGEWAY FUNDS INC | 0.02% | 60,000 | - | - | Dec 29, 2023 |
VANGUARD VALLEY FORGE FUNDS | 0.01% | 6,194 | - | - | Dec 31, 2023 |
VICTORY PORTFOLIOS | 0.00% | 61,460 | - | - | Dec 31, 2023 |
ALPS ETF Trust | 0.00% | 22,298 | - | - | Feb 29, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 723 | - | - | Dec 31, 2023 |
QUANTITATIVE MASTER SERIES LLC | 0.00% | 10,369 | - | - | Dec 31, 2023 |
VANGUARD INDEX FUNDS | 0.00% | 492,946 | - | - | Dec 31, 2023 |
FIDELITY CONCORD STREET TRUST | 0.00% | 95,834 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 12,285 | - | - | Dec 31, 2023 |
RUSSELL INVESTMENT CO | 0.00% | 114,031 | - | - | Jan 31, 2024 |
RUSSELL INVESTMENT FUNDS | 0.00% | 19,247 | - | - | Dec 31, 2023 |
Principal Exchange-Traded Funds | 0.00% | 2,210 | - | - | Mar 31, 2024 |
Calvert Variable Products, Inc. | 0.00% | 422 | - | - | Dec 31, 2023 |
SCHWAB CAPITAL TRUST | 0.00% | 6,722 | - | - | Feb 29, 2024 |
FIDELITY SALEM STREET TRUST | 0.00% | 48,043 | - | - | Feb 29, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 1,500 | - | - | Dec 31, 2023 |
ProFunds | 0.00% | 138 | - | - | Jan 31, 2024 |
RYDEX SERIES FUNDS | 0.00% | 49 | - | - | Dec 31, 2023 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 20,914 | - | - | Feb 29, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 146 | - | - | Feb 29, 2024 |
VALIC Co I | 0.00% | 2,373 | - | - | Feb 29, 2024 |
PROSHARES TRUST | 0.00% | 1,997 | - | - | Feb 29, 2024 |
RYDEX DYNAMIC FUNDS | 0.00% | 30 | - | - | Dec 31, 2023 |
ALLSPRING MASTER TRUST | 0.00% | 358 | - | - | Feb 29, 2024 |
Guggenheim Active Allocation Fund | 0.00% | 33 | - | - | Feb 29, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 717 | - | - | Jan 31, 2024 |
RYDEX VARIABLE TRUST | 0.00% | 6 | - | - | Dec 31, 2023 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 682 | - | - | Dec 31, 2023 |
NORTHERN FUNDS | 0.00% | 3,917 | - | - | Dec 29, 2023 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 339 | - | - | Feb 29, 2024 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 6,200 | - | - | Dec 31, 2023 |
SUNAMERICA SERIES TRUST | 0.00% | 706 | - | - | Jan 31, 2024 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 1,889 | - | - | Dec 31, 2023 |
BLACKROCK FUNDS | 0.00% | 8,163 | - | - | Feb 29, 2024 |
iSHARES TRUST | 0.00% | 17,882 | - | - | Feb 29, 2024 |
EQ ADVISORS TRUST | 0.00% | 1,076 | - | - | Dec 31, 2023 |
PACIFIC SELECT FUND | 0.00% | 2,356 | - | - | Dec 31, 2023 |
BlackRock Variable Series Funds, Inc. | 0.00% | 2,621 | - | - | Dec 31, 2023 |
MASSMUTUAL SELECT FUNDS | 0.00% | 508 | - | - | Dec 31, 2023 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 519 | - | - | Dec 31, 2023 |
Bridge Builder Trust | 0.00% | 1,007 | - | - | Dec 31, 2023 |
PRINCIPAL FUNDS, INC. | 0.00% | 826 | - | - | Feb 29, 2024 |
Impel Pharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 87.48K shares, compromising 0.03% of its total assets.
Impel Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 23 | 2 | -93.55% |
30 Sep, 23 | 31 | - |
30 Jun, 23 | 31 | -3.13% |
31 Mar, 23 | 32 | -8.57% |
31 Dec, 22 | 35 | 2.94% |
30 Sep, 22 | 34 | 6.25% |
30 Jun, 22 | 32 | -23.81% |
31 Mar, 22 | 42 | -4.55% |
31 Dec, 21 | 44 | - |
30 Sep, 21 | 44 | 33.33% |
30 Jun, 21 | 33 | - |
As of 31 Dec 23, 2 institutions are holding Impel Pharmaceuticals's shares, representing a decrease of -93.55% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 23 | 2,761,291 | -83.85% |
30 Sep, 23 | 17,095,707 | -2.54% |
30 Jun, 23 | 17,540,983 | -0.84% |
31 Mar, 23 | 17,688,775 | -1.23% |
31 Dec, 22 | 17,909,446 | 18.07% |
30 Sep, 22 | 15,168,517 | 0.55% |
30 Jun, 22 | 15,085,049 | 0.43% |
31 Mar, 22 | 15,020,941 | -1.64% |
31 Dec, 21 | 15,271,843 | -16.39% |
30 Sep, 21 | 18,266,292 | 7.97% |
30 Jun, 21 | 16,918,302 | - |
Impel Pharmaceuticals (IMPL) has 2.76M shares outstanding as of 31 Dec 23, down -83.85% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 23 | 11.63% | 0.22% |
30 Sep, 23 | 71.99% | 1.32% |
30 Jun, 23 | 73.87% | 1.33% |
31 Mar, 23 | 74.49% | 1.31% |
31 Dec, 22 | 75.44% | 1.84% |
30 Sep, 22 | 63.98% | 1.51% |
30 Jun, 22 | 65.08% | 1.55% |
31 Mar, 22 | 64.90% | 1.48% |
31 Dec, 21 | 66.20% | 0.81% |
30 Sep, 21 | 90.65% | 0.63% |
30 Jun, 21 | 119.82% | - |
As of 31 Dec 23, Impel Pharmaceuticals is held by 11.63% institutional shareholders, representing a 0.22% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 23 | - | -100.00% |
30 Sep, 23 | 9 | 80.00% |
30 Jun, 23 | 5 | -44.44% |
31 Mar, 23 | 9 | -30.77% |
31 Dec, 22 | 13 | - |
30 Sep, 22 | 13 | 30.00% |
30 Jun, 22 | 10 | -44.44% |
31 Mar, 22 | 18 | -40.00% |
31 Dec, 21 | 30 | 7.14% |
30 Sep, 21 | 28 | -15.15% |
30 Jun, 21 | 33 | - |
- institutional shareholders have increased their position in IMPL stock as of 31 Dec 23 compared to 9 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 23 | - | -100.00% |
30 Sep, 23 | 6 | 20.00% |
30 Jun, 23 | 5 | -28.57% |
31 Mar, 23 | 7 | -30.00% |
31 Dec, 22 | 10 | 42.86% |
30 Sep, 22 | 7 | -50.00% |
30 Jun, 22 | 14 | 16.67% |
31 Mar, 22 | 12 | 200.00% |
31 Dec, 21 | 4 | -55.56% |
30 Sep, 21 | 9 | - |
30 Jun, 21 | - | - |
- institutional shareholders have reduced their position in IMPL stock as of 31 Dec 23 compared to 6 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 23 | 2 | -93.55% | 2,761,291 | -83.85% | 11.63% | 0.22% | - | -100.00% | - | -100.00% |
30 Sep, 23 | 31 | - | 17,095,707 | -2.54% | 71.99% | 1.32% | 9 | 80.00% | 6 | 20.00% |
30 Jun, 23 | 31 | -3.13% | 17,540,983 | -0.84% | 73.87% | 1.33% | 5 | -44.44% | 5 | -28.57% |
31 Mar, 23 | 32 | -8.57% | 17,688,775 | -1.23% | 74.49% | 1.31% | 9 | -30.77% | 7 | -30.00% |
31 Dec, 22 | 35 | 2.94% | 17,909,446 | 18.07% | 75.44% | 1.84% | 13 | - | 10 | 42.86% |
30 Sep, 22 | 34 | 6.25% | 15,168,517 | 0.55% | 63.98% | 1.51% | 13 | 30.00% | 7 | -50.00% |
30 Jun, 22 | 32 | -23.81% | 15,085,049 | 0.43% | 65.08% | 1.55% | 10 | -44.44% | 14 | 16.67% |
31 Mar, 22 | 42 | -4.55% | 15,020,941 | -1.64% | 64.90% | 1.48% | 18 | -40.00% | 12 | 200.00% |
31 Dec, 21 | 44 | - | 15,271,843 | -16.39% | 66.20% | 0.81% | 30 | 7.14% | 4 | -55.56% |
30 Sep, 21 | 44 | 33.33% | 18,266,292 | 7.97% | 90.65% | 0.63% | 28 | -15.15% | 9 | - |
30 Jun, 21 | 33 | - | 16,918,302 | - | 119.82% | - | 33 | - | - | - |
Impel Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Impel Pharmaceuticals's stock was made by Vivo Capital VIII, LLC on Dec 19 2023, selling 87,934 shares at $0.29 per share (valued at $25.50K).
Impel Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2023 | 3 | 6 | 50.00% |
Q2 2023 | 8 | 2 | 400.00% |
Q1 2023 | 4 | 5 | 80.00% |
Q4 2022 | 1 | 2 | 50.00% |
Q2 2022 | 5 | - | - |
Q1 2022 | 6 | - | - |
Q4 2021 | 4 | - | - |
Q3 2021 | 16 | 3 | 533.33% |
Q2 2021 | 40 | 70 | 57.14% |
3 total buy trades, and 6 total sell trades (buy/sell ratio of 0.50%) were made by Impel Pharmaceuticals's insiders, as of Q4 2023.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2023 | - | 6 | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | 1 | - | - |
Q3 2021 | 3 | - | - |
Q2 2021 | 6 | - | - |
As of Q4 2023, Insider owners conducted 0 open market buy trades and 6 open market sell trades of Impel Pharmaceuticals's stocks.
Impel Pharmaceuticals Peer Ownership
Ticker | Company |
---|---|
CVKD | Cadrenal Therapeutics, Inc. Common Stock |
ANTX | AN2 Therapeutics, Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
SNTI | Senti Biosciences, Inc. |
PMVP | PMV Pharmaceuticals, Inc. |
QNRX | Quoin Pharmaceuticals, Ltd. |
FHTX | Foghorn Therapeutics Inc. |
ENOB | Renovaro Biosciences Inc. |
CYT | Cyteir Therapeutics, Inc. |
ELYM | Eliem Therapeutics, Inc. |
HCWB | HCW Biologics Inc. |
ELDN | Eledon Pharmaceuticals, Inc. |
ACXP | Acurx Pharmaceuticals, Inc. |
PTIX | Protagenic Therapeutics, Inc. |
CADL | Candel Therapeutics, Inc. |
MNPR | Monopar Therapeutics Inc. |
CYTO | Altamira Therapeutics Ltd. |
ATXI | Avenue Therapeutics, Inc. |
SONN | Sonnet BioTherapeutics Holdings, Inc. |
IMPL Ownership FAQ
Who Owns Impel Pharmaceuticals?
Impel Pharmaceuticals is owned by institutional shareholders (11.63%), insiders (0.52%), and public (87.85%). The largest institutional shareholder of Impel Pharmaceuticals is ST GERMAIN D J CO INC (0% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.03% of total shares).
Who are the major institutional shareholders of Impel Pharmaceuticals?
Impel Pharmaceuticals's major institutional shareholders are ST GERMAIN D J CO INC, and VENBIO PARTNERS LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Impel Pharmaceuticals shareholders are there?
As of Dec 2023, there are 2 institutional shareholders of Impel Pharmaceuticals.
What percentage of Impel Pharmaceuticals is owned by ST GERMAIN D J CO INC?
ST GERMAIN D J CO INC owns 0 shares of Impel Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).
What percentage of Impel Pharmaceuticals is owned by VENBIO PARTNERS LLC?
As of Mar 2024, VENBIO PARTNERS LLC holds 0 shares of Impel Pharmaceuticals (IMPL), compromising 0% of the company, valued at $0.